Acutus Medical Inc
AFIB
AFIB was delisted on the 8th of May, 2024.
38 hedge funds and large institutions have $6.96M invested in Acutus Medical Inc in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 4 closing their positions.
257% more call options, than puts
Call options by funds: $25K | Put options by funds: $7K
0% more funds holding
Funds holding: 38 → 38 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
34% less capital invested
Capital invested by funds: $10.6M → $6.96M (-$3.66M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$785K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$203K |
| 3 |
Renaissance Technologies
New York
|
+$118K |
| 4 |
Cerity Partners
New York
|
+$83.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$61.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$917K |
| 2 |
Morgan Stanley
New York
|
-$135K |
| 3 |
KSCM
Kamunting Street Capital Management
Miami Beach,
Florida
|
-$104K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$73.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$19.4K |
AFIB Hedge Fund Activity: Q1 2023 in Review
38 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Acutus Medical Inc (AFIB) for Q1 2023, worth a combined $6.96M — down 34% from $10.6M a quarter earlier.
Fund positioning in AFIB was balanced in Q1 2023: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 10 trimmed.
The largest buyer was Parkman Healthcare Partners, adding an estimated $785K. The largest seller was Capital World Investors, exiting entirely with an estimated $917K sold.
- 38 institutional investors held Acutus Medical Inc (AFIB) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $6.96M of Acutus Medical Inc stock for Q1 2023, down 34% quarter-over-quarter.
- 4 funds opened new Acutus Medical Inc positions in Q1 2023 and 4 closed out, a net change of 0 holders.
- The largest Acutus Medical Inc buyer in Q1 2023 was Parkman Healthcare Partners, an estimated $785K added.
- The largest Acutus Medical Inc seller in Q1 2023 was Capital World Investors, an estimated $917K sold.
Based on aggregated 13F filings for Q1 2023.